GlassScriptPhysician profile
Christina Vaughan
NPI 1760253637
$1,443.96
in general payments reported to CMS, 2019-2025
12 companies · $587 in 2025
The $587 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $857 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $317.31 | 2024-2025 | Lokelma, Farxiga, Brilinta |
| Abbott Laboratories | $259.05 | 2024 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $221.92 | 2024-2025 | Lifevest |
| Esperion Therapeutics, INC. | $133.43 | 2024-2025 | Nexletol |
| Biosense Webster, INC. | $125.00 | 2024 | Carto 3 |
| Merck Sharp & Dohme LLC | $111.70 | 2024-2025 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $93.96 | 2024 | |
| Janssen Pharmaceuticals, INC | $60.68 | 2024 | Xarelto |
| Amgen INC. | $47.92 | 2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.41 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $20.43 | 2025 | |
| Bard Peripheral Vascular, INC. | $13.15 | 2024 | Crosser Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Vaughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.